-
Radiopharmaceutical for prostate cancer treatment readied for trials
A new targeted radiopharmaceutical, designed to deliver a therapeutic dose of radiation directly to metastatic prostate cancer, will be manufactured in Hamilton, Ont. It will be used in clinical trials to evaluate its efficacy and benefits for patients.